ArticleOncoimmunology2021

Ectopic CD137 expression by rhabdomyosarcoma provides selection advantages but allows immunotherapeutic targeting.

Kang Yi Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.